ArticleNeuro-oncology2017

VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties.

Tasleem Arif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.